proxyvotesnow.com

Home › Asset managers › BNY Mellon › 2025-2026 › Against the board

BNY Mellon 2025-2026: where it broke with the board

4,138 proposals in the 2025-2026 proxy season: BNY Mellon voted against, or withheld its votes from, 4,127 proposals put forward by company boards, and voted for 11 shareholder proposals, by its own Form N-PX filings.

Two kinds of vote are listed: a board-sponsored proposal BNY Mellon voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

4,138 proposals.

BNY Mellon, 2025-2026 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see how we count these.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedBNY Mellon votedFunds
Lockheed Martin Corporation May 12, 2026 Election of Nine Directors: Thomas J. Falk Director Elections Board AGAINST 1
Lockheed Martin Corporation May 12, 2026 Ratification of the Appointment of Ernst & Young as our Independent Auditors for 2026 Audit-related Board AGAINST 1
Loews Corporation May 12, 2026 Approve, on an advisory basis, executive compensation Say-on-Pay Board AGAINST 1
Loews Corporation May 12, 2026 Ratify Deloitte & Touche LLP as independent auditors Audit-related Board AGAINST 1
Longfor Group Holdings Limited June 18, 2026 Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration Audit-related Board AGAINST 1
Loongson Technology Corp. Ltd. October 15, 2025 Approve Authorization of the Board to Handle All Related Matters Compensation Board AGAINST 1
Loongson Technology Corp. Ltd. October 15, 2025 Approve Draft and Summary of Performance Share Incentive Plan Compensation Board AGAINST 1
Loongson Technology Corp. Ltd. October 15, 2025 Approve Methods to Assess the Performance of Plan Participants Compensation Board AGAINST 1
Lotte Corp. March 24, 2026 Elect Shin Dong-bin as Inside Director Director Elections Board AGAINST 1
Lucid Group, Inc. June 4, 2026 Election of directors: Silvio Napoli Director Elections Board WITHHOLD 1
Lucid Group, Inc. June 4, 2026 To approve the amendment and restatement of the Lucid Group, Inc. Amended and Restated 2021 Stock Incentive Plan Compensation Board AGAINST 1
Luminar Technologies, Inc. July 3, 2025 To approve on an advisory (non-binding) basis of the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 1
Lundin Mining Corporation May 7, 2026 Elect Director Adam I. Lundin Director Elections Board AGAINST 1
Luxshare Precision Industry Co. Ltd. December 22, 2025 Approve Estimated Amount of External Guarantees Capital Structure Board AGAINST 1
M&T Bank Corporation April 21, 2026 TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE 2025 COMPENSATION OF M&T BANK CORPORATION'S NAMED EXECUTIVE OFFICERS. Say-on-Pay Board AGAINST 1
M&T Bank Corporation April 21, 2026 TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF M&T BANK CORPORATION FOR THE YEAR ENDING DECEMBER 31, 2026. Audit-related Board AGAINST 1
MBIA Inc. May 5, 2026 To approve, on an advisory basis, executive compensation. Say-on-Pay Board (inferred) AGAINST 1
MGM China Holdings Limited May 14, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 1
MGM China Holdings Limited May 14, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 1
MOL Hungarian Oil & Gas Plc April 10, 2026 Approve Remuneration Report Compensation Board AGAINST 1
MRF Limited March 28, 2026 Approve Revision in the Terms of Remuneration of Arun Mammen as Vice Chairman and Managing Director Compensation Board AGAINST 1
MRF Limited March 28, 2026 Approve Revision in the Terms of Remuneration of K M Mammen as Chairman and Managing Director Compensation Board AGAINST 1
MRF Limited March 28, 2026 Approve Revision in the Terms of Remuneration of Rahul Mammen Mappillai as Managing Director Compensation Board AGAINST 1
MRF Limited March 28, 2026 Approve Revision in the Terms of Remuneration of Samir Thariyan Mappillai as Whole-Time Director Compensation Board AGAINST 1
MRF Limited March 28, 2026 Approve Revision in the Terms of Remuneration of Varun Mammen as Whole-Time Director Compensation Board AGAINST 1
Mainfreight Limited July 30, 2025 Elect Simon Cotter as Director Director Elections Board AGAINST 1
MakeMyTrip Limited September 11, 2025 Reelect Director Mohit Kabra Director Elections Board AGAINST 1
Manila Electric Company June 30, 2026 Elect James L. Go as Director Director Elections Board AGAINST 1
Manila Electric Company June 30, 2026 Elect Jose Ma. K. Lim as Director Director Elections Board AGAINST 1
Manila Electric Company June 30, 2026 Elect June Cheryl A. Cabal-Revilla as Director Director Elections Board AGAINST 1
Manila Electric Company June 30, 2026 Elect Lance Y. Gokongwei as Director Director Elections Board AGAINST 1
Manila Electric Company June 30, 2026 Elect Lydia B. Echauz as Director Director Elections Board AGAINST 1
Manila Electric Company June 30, 2026 Elect Patrick Henry C. Go as Director Director Elections Board AGAINST 1
Manila Electric Company June 30, 2026 Elect Ray C. Espinosa as Director Director Elections Board AGAINST 1
Manila Electric Company June 30, 2026 Elect Victorico P. Vargas as Director Director Elections Board AGAINST 1
Mao Geping Cosmetics Co., Ltd. December 4, 2025 Adopt Implementation Measures for Performance Assessment of the Restricted Share Unit Incentive Scheme Compensation Board AGAINST 1
Mao Geping Cosmetics Co., Ltd. December 4, 2025 Approve Restricted Share Unit Incentive Scheme Compensation Board AGAINST 1
Mao Geping Cosmetics Co., Ltd. December 4, 2025 Authorize Board and/or Its Authorized Person to Handle Matters in Relation to Restricted Share Unit Incentive Scheme Compensation Board AGAINST 1
Mapfre SA March 13, 2026 Reelect Antonio Huertas Mejias as Director Director Elections Board AGAINST 1
Maplebear Inc. May 22, 2026 To elect the following Class III director nominees: Lily Sarafan Director Elections Board WITHHOLD 1
Maplebear Inc. May 22, 2026 To elect the following Class III director nominees: Meredith Kopit Levien Director Elections Board WITHHOLD 1
Marqeta, Inc. June 10, 2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 1
Masco Corporation May 8, 2026 To ratify the selection of PricewaterhouseCoopers LLP as independent auditors for the Company for 2026. Audit-related Board AGAINST 1
Match Group, Inc. June 16, 2026 Election of Directors: Ann L. McDaniel Director Elections Board AGAINST 1
Match Group, Inc. June 16, 2026 Election of Directors: Laura Rachel Jones Director Elections Board AGAINST 1
Match Group, Inc. June 16, 2026 Ratification of the appointment of Ernst & Young LLP as Match Group, Inc.'s independent registered public accounting firm for 2026. Audit-related Board AGAINST 1
Match Group, Inc. June 16, 2026 To approve the Match Group, Inc Second Amended and Restated 2024 Stock and Annual Incentive Plan. Compensation Board AGAINST 1
Mativ Holdings, Inc. April 30, 2026 Non-Binding Advisory Vote to Approve Executive Compensation. Say-on-Pay Board (inferred) AGAINST 1
Mattel, Inc. May 28, 2026 Ratification of the selection of PricewaterhouseCoopers LLP as Mattel, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. Audit-related Board AGAINST 1
Max Financial Services Limited December 21, 2025 Elect Pradeep Pant as Director Director Elections Board AGAINST 1
MaxLinear, Inc. May 20, 2026 To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in the proxy statement. Say-on-Pay Board (inferred) AGAINST 1
Maximus, Inc. March 10, 2026 Advisory vote to approve the compensation of the named executive officers. Say-on-Pay Board AGAINST 1
Maxscend Microelectronics Co., Ltd. July 16, 2025 Approve Authorization of the Board to Handle All Related Matters Compensation Board AGAINST 1
Maxscend Microelectronics Co., Ltd. July 16, 2025 Approve Draft and Summary of Performance Shares Incentive Plan Compensation Board AGAINST 1
Maxscend Microelectronics Co., Ltd. July 16, 2025 Approve Performance Shares Incentive Plan Implementation Assessment Management Measures Compensation Board AGAINST 1
Mazagon Dock Shipbuilders Ltd. September 26, 2025 Elect Kedarnath Gupta as Director Director Elections Board AGAINST 1
Mazagon Dock Shipbuilders Ltd. September 26, 2025 Elect Rajeev Prakash as Director Director Elections Board AGAINST 1
Mazagon Dock Shipbuilders Ltd. September 26, 2025 Elect Ruchir Agrawal as Director (Finance) Director Elections Board AGAINST 1
Mazagon Dock Shipbuilders Ltd. September 26, 2025 Elect S B Jamgaonkar as Director (Submarine & Heavy Engineering) Director Elections Board AGAINST 1
Mazagon Dock Shipbuilders Ltd. September 26, 2025 Reelect Vasudev Puranik as Director Director Elections Board AGAINST 1
Medical Properties Trust, Inc. May 28, 2026 To elect nine directors: C. Reynolds Thompson, III Director Elections Board AGAINST 1
Medical Properties Trust, Inc. May 28, 2026 To elect nine directors: D. Paul Sparks, Jr. Director Elections Board AGAINST 1
Medical Properties Trust, Inc. May 28, 2026 To elect nine directors: Emily W. Murphy Director Elections Board AGAINST 1
Meihua Holdings Group Co., Ltd. May 28, 2026 Approve Use of Idle Own Funds to Invest in Financial Products Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Adjustment Mechanism Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Authorization of the Board to Handle All Related Matters Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Basis and Fairness of Pricing for This Transaction Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Company's Eligibility for Acquisition by Issuance of Shares Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transactions and Validity of the Submitted Legal Documents Regarding this Transaction Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Conditional Agreement on Acquisition by Issuance of Shares and Profit Forecast Compensation Agreement Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Confidentiality Measures and Confidentiality System Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Description of Any Third-party Organization or Individual Hired Directly or Indirectly for Compensation in This Transaction Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Impact of Dilution of Current Returns on Major Financial Indicators and the Relevant Measures to be Taken Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Issue Size Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Issue Type, Par Value and Listing Exchange Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Lock-up Period Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Overall Transaction Plan Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Pricing Basis, Price Reference Date and Issue Price Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Purchase and Sale of Assets within 12 Months Prior to This Transaction Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Relevant Audit Reports, Review Report and Evaluation Report of This Transaction Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Relevant Parties Do Not Exist Condition Stipulated in Article 12 of Regulatory Guidelines for Listed Companies No. 7 Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Report (Draft) and Summary on Company's Acquisition by Issuance of Shares Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Resolution Validity Period Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Stock Price Fluctuations in the 20 Trading Days Before the Announcement of This Transaction Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Target Asset Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Complies with Article 4 of Regulatory Guidelines for Listed Companies No. 9 Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Complies with Articles 11, 43 and 44 of Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Does Not Constitute as Major Adjustment Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Does Not Constitute as Major Asset Restructuring or Restructuring for Listing Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Parties Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve Transaction Price Extraordinary Transactions Board AGAINST 1
Meinian Onehealth Healthcare Holdings Co., Ltd. July 28, 2025 Approve the Company Does Not Exist Condition Stipulated in Article 11 of Measures for the Administration of Registration of Securities Issuance by Listed Companies Extraordinary Transactions Board AGAINST 1
Meitu, Inc. June 5, 2026 Approve PricewaterhouseCoopers as Auditor and Authorize Board to Fix Their Remuneration Audit-related Board AGAINST 1
Meituan June 26, 2026 Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration Audit-related Board AGAINST 1
Melisron Ltd. March 15, 2026 Reappoint Brightman Almagor Zohar & Co. (Deloitte) as Auditors Audit-related Board AGAINST 1
Menora Mivtachim Holdings Ltd. October 5, 2025 Reelect Shay Feldman as Director and Approve His Remuneration Director Elections Board AGAINST 1
Merck & Co., Inc. May 26, 2026 Election of Directors: Thomas H. Glocer Director Elections Board AGAINST 1

← Previous Page 31 of 42 Next →

← Back to BNY Mellon 2025-2026 overview

Built November 8, 2026 from SEC Form N-PX filings.